Sanofi
SNY
$50.05
-$0.53-1.05%
NASDAQ
| 06/30/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | ||
|---|---|---|---|---|---|
| Revenue | -- | 9.46% | -15.16% | -15.09% | |
| Total Other Revenue | -- | 0.82% | 31.02% | 33.83% | |
| Total Revenue | -- | 8.79% | -12.40% | -12.27% | |
| Cost of Revenue | -- | 5.34% | -12.86% | -9.88% | |
| Gross Profit | -- | 10.32% | -12.20% | -13.30% | |
| SG&A Expenses | -- | 2.62% | -26.92% | -22.87% | |
| Depreciation & Amortization | -- | -7.93% | -21.43% | -16.67% | |
| Other Operating Expenses | -- | -2.59% | 38.29% | 79.87% | |
| Total Operating Expenses | -- | 4.70% | -10.35% | -6.76% | |
| Operating Income | -- | 28.11% | -20.60% | -31.60% | |
| Income Before Tax | -- | 16.16% | -57.60% | -59.12% | |
| Income Tax Expenses | -- | 25.28% | -63.63% | -69.51% | |
| Earnings from Continuing Operations | -- | 14.34% | -56.16% | -56.46% | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -63.42% | 53.73% | 67.81% | |
| Net Income | -- | 7.93% | -49.69% | -49.87% | |
| EBIT | -- | 28.11% | -20.60% | -31.60% | |
| EBITDA | -- | 20.45% | -16.32% | -24.08% | |
| EPS Basic | -- | 7.96% | -49.69% | -49.88% | |
| Normalized Basic EPS | -- | 0.22% | -- | -- | |
| EPS Diluted | -- | 7.91% | -49.76% | -49.95% | |
| Normalized Diluted EPS | -- | 0.22% | -- | -- | |
| Average Basic Shares Outstanding | -- | 0.00% | -0.08% | -0.09% | |
| Average Diluted Shares Outstanding | -- | -0.01% | 0.10% | 0.10% | |
| Dividend Per Share | -- | 3.23% | 11.29% | 11.29% | |
| Payout Ratio | -- | -- | -- | -- | |